The EPIC-Norfolk Study

 

Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study.

Kraaijenhof JM, Nurmohamed NS, Nordestgaard AT, Reeskamp LF, Stroes ESG, Hovingh GK, Boekholdt SM, and Ridker PM

European heart journal. Apr 2025

(DOI : 10.1093/eurheartj/ehaf209)

---

The role of systemic inflammation in remnant cholesterol associated cardiovascular risk: insights from the EPIC-Norfolk study.

Kraaijenhof JM, Kerkvliet MJ, Nurmohamed NS, Grefhorst A, Kroon J, Wareham NJ, Hovingh GK, Stroes ESG, Boekholdt SM, and Reeskamp LF

European Journal of Preventive Cardiology. Feb 2025

(DOI : 10.1093/eurjpc/zwaf037)

---

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention.

Hoogeveen RM, Pereira JPB, Nurmohamed NS, Zampoleri V, Bom MJ, Baragetti A, Boekholdt SM, Knaapen P, Khaw KT, Wareham NJ, Groen AK, Catapano AL, Koenig W, Levin E, and Stroes ESG

European heart journal. Nov 2019

(DOI : 10.1093/eurheartj/ehaa648)

---